Press coverage about Rite Aid Corporation (NYSE:RAD) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Rite Aid Corporation earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.5330939234011 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:
- Rite Aid Corporation (RAD) Stock Can’t Avoid the Murky Waters Ahead (investorplace.com)
- Rite Aid Corporation (RAD) Stock Can’t Avoid the Murky Waters Ahead (investorplace.com)
- Ugly Rite Aid Corporation (RAD) Stock Has Upside Potential, If You Can Stomach It (investorplace.com)
- 3 Top Retail Stocks Under $10 (fool.com)
- Calpine Corp (CPN), and Rite Aid Corp (RAD) Seeing Increased Action in Session - FLBC News (flbcnews.com)
Shares of Rite Aid Corporation (RAD) opened at 2.25 on Thursday. The company’s 50-day moving average price is $2.35 and its 200 day moving average price is $3.80. Rite Aid Corporation has a 12-month low of $2.21 and a 12-month high of $8.77. The firm’s market capitalization is $2.36 billion.
Rite Aid Corporation (NYSE:RAD) last released its earnings results on Thursday, June 29th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by $0.04. The business had revenue of $7.78 billion during the quarter, compared to the consensus estimate of $8.29 billion. Rite Aid Corporation had a negative net margin of 0.21% and a positive return on equity of 0.52%. The firm’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period last year, the business posted $0.02 EPS. On average, equities research analysts forecast that Rite Aid Corporation will post ($0.09) EPS for the current fiscal year.
A number of equities research analysts recently weighed in on the company. Mizuho cut Rite Aid Corporation from a “buy” rating to a “neutral” rating and set a $2.95 price objective for the company. in a research note on Thursday, July 20th. Zacks Investment Research cut Rite Aid Corporation from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 4th. Guggenheim reiterated a “neutral” rating on shares of Rite Aid Corporation in a research note on Monday, July 3rd. Cowen and Company reiterated an “outperform” rating and issued a $4.70 price target on shares of Rite Aid Corporation in a research note on Monday, July 3rd. Finally, Bank of America Corporation reiterated an “underperform” rating and issued a $2.00 price target on shares of Rite Aid Corporation in a research note on Friday, June 30th. Three research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. Rite Aid Corporation presently has a consensus rating of “Hold” and a consensus target price of $4.53.
About Rite Aid Corporation
Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.
Receive News & Ratings for Rite Aid Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
